Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Nov-23 10:00 PM View:  | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 10-Nov-23 | Sale | 4,764,010 | $0.29 | $1,401,570.00 | (100%) 4.76M to 0 | |
| 13-Mar-24 5:56 PM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 20-Oct-23 | Grant | 3,500 | $0.13 | $466.55 | < 1% 402.92K to 406.42K | |
| 28-Apr-23 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 27-Apr-23 | Purchase | 47,000 | $0.75 | $35,250.00 | 13% 352.42K to 399.42K | |
| 28-Apr-23 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 26-Apr-23 | Private Purchase | 3,999 | $0.66 | $2,639.34 | 1% 348.42K to 352.42K | |
| 13-Mar-24 5:56 PM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 20-Apr-23 | Grant | 3,500 | $0.14 | $481.95 | < 1% 399.42K to 402.92K | |
| 13-Mar-24 5:59 PM View: | Brown Scott B. Chief Financial Officer | Tracon Pharmaceuticals, Inc. (TCON) | 20-Apr-23 | Grant | 3,500 | $0.14 | $481.95 | 16% 21.63K to 25.13K | |
| 13-Mar-23 4:05 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 09-Mar-23 | Private Purchase | 174,508 | $1.38 | $240,821.00 | 4% 4.15M to 4.32M | |
| 02-Mar-23 6:24 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 01-Mar-23 | Purchase | 4,800 | $1.52 | $7,296.00 | 1% 340.12K to 344.92K | |
| 02-Mar-23 6:24 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 28-Feb-23 | Private Purchase | 200 | $1.52 | $304.00 | < 1% 339.92K to 340.12K | |
| 19-Jan-23 6:05 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 18-Jan-23 | Private Purchase | 6,800 | $1.62 | $11,016.00 | 2% 333.12K to 339.92K | |
| 03-Jan-23 6:00 AM View: | Brown Scott B. Chief Financial Officer | Tracon Pharmaceuticals, Inc. (TCON) | 29-Dec-22 | Private Purchase | 3,500 | $1.49 | $5,215.00 | 19% 18.13K to 21.63K | |
| 19-Jan-23 6:00 AM View: | Larue William R Director | Tracon Pharmaceuticals, Inc. (TCON) | 21-Dec-22 | Sale | 120 | $1.26 | $150.64 | (2%) 7.88K to 7.76K | |
| 15-Dec-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 14-Dec-22 | Private Purchase | 23,000 | $1.29 | $29,755.10 | 7% 310.12K to 333.12K | |
| 16-Dec-22 5:03 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 14-Dec-22 | Private Purchase | 167,500 | $1.25 | $209,876.00 | 4% 4.42M to 4.59M | |
| 08-Dec-22 6:49 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 06-Dec-22 | Sale | 1,539 | $1.44 | $2,216.16 | (< 1%) 8.14M to 8.13M | |
| 08-Dec-22 6:49 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 06-Dec-22 | Exercise (in-the money or at-the-money) | 221,539 | $0.01 | $2,215.39 | 3% 7.92M to 8.14M | |
| 22-Nov-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 18-Nov-22 | Private Purchase | 13,900 | $1.41 | $19,599.00 | 5% 296.22K to 310.12K | |
| 04-Nov-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 03-Nov-22 | Private Purchase | 9,200 | $1.52 | $13,984.00 | 3% 287.02K to 296.22K | |
| 03-Nov-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 02-Nov-22 | Private Purchase | 6,000 | $1.59 | $9,540.00 | 2% 281.02K to 287.02K | |
| 19-Oct-22 7:22 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 18-Oct-22 | Private Purchase | 12,500 | $1.65 | $20,625.00 | < 1% 7.9M to 7.92M | |
| 11-Oct-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 07-Oct-22 | Private Purchase | 5,000 | $1.77 | $8,850.00 | 2% 272.52K to 277.52K | |
| 05-Oct-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 03-Oct-22 | Private Purchase | 5,000 | $1.67 | $8,350.00 | 2% 267.52K to 272.52K | |
| 03-Oct-22 4:06 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 29-Sep-22 | Private Purchase | 9,400 | $1.74 | $16,370.10 | 2% 400.6K to 410.0K | |
| 28-Sep-22 6:00 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 27-Sep-22 | Private Purchase | 1,700 | $1.69 | $2,877.08 | < 1% 398.9K to 400.6K | |
| 26-Sep-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 22-Sep-22 | Private Purchase | 5,000 | $1.76 | $8,800.00 | 2% 262.52K to 267.52K | |
| 22-Sep-22 6:09 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 22-Sep-22 | Private Purchase | 17,311 | $1.73 | $29,942.80 | < 1% 4.16M to 4.18M | |
| 20-Sep-22 5:37 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 20-Sep-22 | Private Purchase | 10,000 | $1.85 | $18,524.00 | 3% 375.0K to 385.0K | |
| 19-Sep-22 7:00 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 19-Sep-22 | Private Purchase | 5,000 | $1.87 | $9,366.50 | 1% 370.0K to 375.0K | |
| 14-Sep-22 4:05 PM View: | Brown Scott B. Chief Financial Officer | Tracon Pharmaceuticals, Inc. (TCON) | 12-Sep-22 | Private Purchase | 2,500 | $2.02 | $5,037.50 | 21% 12.13K to 14.63K | |
| 26-Jul-22 5:25 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 26-Jul-22 | Private Purchase | 2,254 | $1.72 | $3,876.88 | < 1% 367.75K to 370.0K | |
| 25-Jul-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 22-Jul-22 | Private Purchase | 4,500 | $1.85 | $8,325.00 | 2% 258.02K to 262.52K | |
| 15-Jul-22 6:06 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 15-Jul-22 | Private Purchase | 11,826 | $1.78 | $21,068.00 | 3% 355.92K to 367.75K | |
| 14-Jul-22 6:25 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 14-Jul-22 | Private Purchase | 7,187 | $1.81 | $13,024.30 | 2% 348.73K to 355.92K | |
| 14-Jul-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 13-Jul-22 | Purchase | 3,000 | $1.84 | $5,520.00 | 1% 255.02K to 258.02K | |
| 14-Jul-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 12-Jul-22 | Private Purchase | 3,000 | $1.87 | $5,610.00 | 1% 252.02K to 255.02K | |
| 27-Jun-22 4:05 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 24-Jun-22 | Private Purchase | 11,419 | $1.39 | $15,894.10 | 3% 337.31K to 348.73K | |
| 23-Jun-22 6:54 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 21-Jun-22 | Private Purchase | 841,989 | $1.31 | $1,105,280.00 | 29% 2.93M to 3.78M | |
| 10-May-22 7:58 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 10-May-22 | Private Purchase | 9,700 | $1.76 | $17,032.20 | < 1% 3.26M to 3.27M | |
| 11-May-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 09-May-22 | Private Purchase | 10,000 | $1.85 | $18,500.00 | 4% 242.02K to 252.02K | |
| 10-May-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 06-May-22 | Private Purchase | 2,500 | $1.97 | $4,925.00 | 1% 239.52K to 242.02K | |
| 03-May-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 29-Apr-22 | Private Purchase | 5,000 | $1.97 | $9,854.50 | 2% 234.52K to 239.52K | |
| 25-Apr-22 5:55 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 25-Apr-22 | Purchase | 10,777 | $2.18 | $23,497.10 | < 1% 3.24M to 3.26M | |
| 25-Apr-22 5:55 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 22-Apr-22 | Private Purchase | 42,000 | $2.24 | $93,941.40 | 1% 3.2M to 3.24M | |
| 29-Apr-22 6:27 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 22-Apr-22 | Private Purchase | 7,100 | $1.98 | $14,058.00 | < 1% 3.26M to 3.26M | |
| 25-Apr-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 21-Apr-22 | Private Purchase | 4,500 | $2.30 | $10,350.00 | 2% 230.02K to 234.52K | |
| 14-Apr-22 6:13 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 14-Apr-22 | Market Purchase | 12,696 | $2.50 | $31,729.80 | < 1% 3.19M to 3.2M | 8% |
| 14-Apr-22 6:13 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 13-Apr-22 | Market Purchase | 7,345 | $2.50 | $18,361.00 | < 1% 3.18M to 3.19M | 8% |
| 12-Apr-22 7:38 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 12-Apr-22 | Purchase | 18,098 | $2.48 | $44,826.90 | < 1% 3.16M to 3.18M | |
| 12-Apr-22 7:38 PM View: | Opaleye Management Inc. 10% Owner | Tracon Pharmaceuticals, Inc. (TCON) | 11-Apr-22 | Private Purchase | 9,100 | $2.42 | $22,019.30 | < 1% 3.16M to 3.16M | |
| 12-Apr-22 6:00 AM View: | Theuer Charles President and CEO Director | Tracon Pharmaceuticals, Inc. (TCON) | 08-Apr-22 | Market Purchase | 2,000 | $2.50 | $5,000.00 | < 1% 224.52K to 226.52K | 8% |
